Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DEMULDER PHM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 55 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. KRIS MG; ROILA F; DEMULDER PHM; MARTY M
      DELAYED EMESIS FOLLOWING ANTICANCER CHEMOTHERAPY

      Supportive care in cancer
    2. DEMULDER PHM; ROILA F; KRIS MG; MARTY MM
      CONSENSUS REGARDING MULTIPLE DAY AND RESCUE ANTIEMETIC THERAPY

      Supportive care in cancer
    3. ROILA F; DELFAVERO A; GRALLA RJ; TONATO M; AAPRO MS; ANDREWS PLR; BALLATORI E; DEMULDER PHM; DICATO MA; DUBOIS A; FEYER PC; GANDARA DR; GRALLA RJ; GRALLA RJ; GROSHEN S; GRUNBERG SM; HERRSTEDT J; HESKETH PJ; JOSS RA; KRIS MG; MARTY MM; MORROW GR; NAYLOR RJ; OLVER IN; SMYTH JF; SPITZER TR; STEWART A
      PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE

      Annals of oncology
    4. TJANHEIJNEN VCG; VLASVELD LT; DEMULDER PHM
      SEMINOMA AND SARCOIDOSIS - A CAUSE FOR FALSE-POSITIVE MEDIASTINAL UPTAKE IN PET - RESPONSE

      Annals of oncology
    5. TJANHEIJNEN VCG; VLASVELD LT; PERNET EPPM; PAUWELS P; DEMULDER PHM
      COINCIDENCE OF SEMINOMA AND SARCOIDOSIS - A MYTH OR FACT

      Annals of oncology
    6. LOUWERENS M; SCHORNAGEL J; DEMULDER PHM; DEWIT R
      A DOSE-FINDING STUDY OF PACLITAXEL (TAXOL) ADDED TO FIXED DOSES OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) IN PATIENTS WITH ADVERSE PROGNOSISGERM-CELL CANCER OR CARCINOMA OF UNKNOWN PRIMARY (CUP)

      Annals of oncology
    7. FOSSA SD; KAYE SB; MEAD GM; CULLEN M; DEWIT R; BODROGI I; VANGROENINGEN CJ; DEMULDER PHM; STENNING S; LALLEMAND E; DEPRIJCK L; COLLETTE L
      FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY

      Journal of clinical oncology
    8. STEFFENS MG; BOERMAN OC; OOSTERWIJK E; OYEN WJG; DEMULDER PHM; WITJES JA; OOSTERHOF GON; DEBRUYNE FMJ; CORSTENS FHM
      PHASE I II RADIOIMMUNOTHERAPY WITH I-131-LABELED CHIMERIC MONOCLONAL-ANTIBODY CG250 IN PATIENTS WITH METASTASIZED RENAL-CELL CARCINOMA/

      The Journal of nuclear medicine
    9. STEFFENS MG; BOERMAN OC; OYEN WJG; DEMULDER PHM; WITJES JA; OOSTERHOF GON; CORSTENS FHM; DEBRUYNE FMJ; OOSTERWIJK E
      RADIOIMMUNOTHERAPY WITH I-131 CG250 MONOCLONAL-ANTIBODY IN PATIENTS WITH METASTASIZED RCC, A PHASE I II STUDY/

      The Journal of urology
    10. DEWIT R; COLLETTE L; SYLVESTER R; DEMULDER PHM; SLEIJFER DT; HUININK WWT; KAYE SB; VANOOSTEROM AT; BOVEN E; STOTER G
      SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE

      British Journal of Cancer
    11. DEWIT R; PAWINSKY A; STOTER G; VANOOSTEROM AT; FOSSA SD; PARIDAENS R; SVEDBERG A; DEMULDER PHM
      EORTC PHASE-II STUDY OF DAILY ORAL LINOMIDE IN METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH GOOD PROGNOSTIC FACTORS

      European journal of cancer
    12. PAWINSKI A; VANOOSTEROM AT; DEWIT R; FOSSA S; CROLES J; SVEDBERG A; LENTZ MA; DEMULDER PHM
      AN EORTC PHASE-II STUDY OF THE EFFICACY AND SAFETY OF LINOMIDE IN THETREATMENT OF ADVANCED RENAL-CELL CARCINOMA

      European journal of cancer
    13. PLANTING AST; DEMULDER PHM; DEGRAEFF A; VERWEIJ J
      PHASE-II STUDY OF WEEKLY HIGH-DOSE CISPLATIN FOR 6 CYCLES IN PATIENTSWITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      European journal of cancer
    14. TJANHEIJNEN VCG; OOSTERHOF GON; DEWIT R; DEMULDER PHM
      TREATMENT IN GERM-CELL TUMORS - STATE-OF-THE-ART

      European journal of surgical oncology
    15. HORWICH A; SLEIJFER DT; FOSSA SD; KAYE SB; OLIVER RTD; CULLEN MH; MEAD GM; DEWIT R; DEMULDER PHM; DEARNALEY DP; COOK PA; SYLVESTER RJ; STENNING SP
      RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL

      Journal of clinical oncology
    16. MEAD GM; STENNING SP; COOK P; FOSSA SD; HORWICH A; KAYE SB; OLIVER RTD; DEMULDER PHM; DEWIT R; STOTER G; SYLVESTER RJ; BAJORIN DF; BOSL GJ; MAZUMDAR M; NICHOLS CR; AMATO R; PIZZOCARO G; DROZ JP; KRAMAR A; DAUGAARD G; CORTESFUNES H; PAZARES L; LEVI JA; COLLS BM; HARVEY VJ; COPPIN C
      INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS

      Journal of clinical oncology
    17. PUNT CJA; VANHERPEN CML; JANSEN RLH; VREUGDENHIL G; MULLER EW; DEMULDER PHM
      CHEMOIMMUNOTHERAPY WITH BLEOMYCIN, VINCRISTINE, LOMUSTINE, DACARBAZINE (BOLD) PLUS INTERFERON-ALPHA FOR METASTATIC MELANOMA - A MULTICENTERPHASE-II STUDY

      British Journal of Cancer
    18. PUNT CJA; VOEST EE; TUENI E; VANOOSTEROM AT; BACKX A; DEMULDER PHM; HECQUET B; LUCAS C; GERARD B; BLEIBERG H
      PHASE IB STUDY OF DOXORUBICIN IN COMBINATION WITH THE MULTIDRUG-RESISTANCE REVERSING AGENT S9788 IN ADVANCED COLORECTAL AND RENAL-CELL CANCER

      British Journal of Cancer
    19. DEWIT R; SYLVESTER R; TSITSA C; DEMULDER PHM; SLEYFER DT; HUININK WWT; KAYE SB; VANOOSTEROM AT; BOVEN E; VERMEYLEN K; STOTER G
      TUMOR-MARKER CONCENTRATION AT THE START OF CHEMOTHERAPY IS A STRONGERPREDICTOR OF TREATMENT FAILURE THAN MARKER HALF-LIFE - A STUDY IN PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER

      British Journal of Cancer
    20. VERWEIJ J; DEMULDER PHM; DEGRAEFF A; VERMORKEN JB; WILDIERS J; KERGER J; SCHORNAGEL J; COGNETTI F; KIRKPATRICK A; SAHMOUD T; LEFEBVRE JL
      PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK

      Annals of oncology
    21. VERHAGEN CAHHVM; VANHOESEL QGCM; SCHIJF CPT; DEMULDER PHM
      THE MANAGEMENT OF GRANULOSA-CELL TUMOR OF THE OVARY - A CASE-HISTORY

      Annals of oncology
    22. DEWIT R; SCHMITZ PIM; VERWEIJ J; DEBOERDENNERT M; DEMULDER PHM; PLANTING AST; VANDERBURG MEL; STOTER G
      ANALYSIS OF CUMULATIVE PROBABILITIES SHOWS THAT THE EFFICACY OF 5HT(3) ANTAGONIST PROPHYLAXIS IS NOT MAINTAINED

      Journal of clinical oncology
    23. DEMULDER PHM; WEISSBACH L; JAKSE G; OSIEKA R; BLATTER J
      GEMCITABINE - A PHASE-II STUDY IN PATIENTS WITH ADVANCED RENAL-CANCER

      Cancer chemotherapy and pharmacology
    24. ROHDE D; DEMULDER PHM; WEISSBACH L; OSIEKA R; BLATTER J; JAKSE G
      EXPERIMENTAL AND CLINICAL EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AGAINST RENAL-CELL CARCINOMA

      Oncology
    25. VERWEIJ J; DEWIT R; DEMULDER PHM
      OPTIMAL-CONTROL OF ACUTE CISPLATIN-INDUCED EMESIS

      Oncology
    26. KRUIT WHJ; PUNT CJA; GOEY SH; DEMULDER PHM; GRATAMA JW; EGGERMONT AMM; BOLHUIS RLH; STOTER G
      DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA

      British Journal of Cancer
    27. VERWEIJ J; WANDERS J; GIL T; SCHOFFSKI P; CATIMEL G; TEVELDE A; DEMULDER PHM
      PHASE-II STUDY OF RHIZOXIN IN SQUAMOUS-CELL HEAD AND NECK-CANCER

      British Journal of Cancer
    28. STEERENBERG PA; BALEMANS LTM; KREMER BHA; KOPPENHAGEN FJ; DEMULDER PHM; DENOTTER W
      REDUCTION OF THERAPEUTIC EFFICACY BY A 2ND CYCLE OF PEG-IL-2

      Journal of immunotherapy with emphasis on tumor immunology
    29. BRAUSI M; JONES WG; FOSSA SD; DEMULDER PHM; DROZ JP; LENTZ MA; VANGLABBEKE M; PAWINSKI A
      HIGH-DOSE EPIRUBICIN IS EFFECTIVE IN MEASURABLE METASTATIC PROSTATE-CANCER - A PHASE-II STUDY OF THE EORTC GENITOURINARY GROUP

      European journal of cancer
    30. PLANTING AST; VERMORKEN JB; CATIMEL G; DEMULDER PHM; DEGRAEFF A; OSTER W; VERDONK HER
      RANDOMIZED PHASE-II STUDY OF WEEKLY CISPLATIN WITH OR WITHOUT AMIFOSTINE IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER

      European journal of cancer
    31. PAWINSKI A; VANOOSTEROM AT; DEMULDER PHM; STOTER G; SVEDBERG A
      THE EFFICACY AND SAFETY OF LINOMIDE IN THE TREATMENT OF RENAL-CELL CARCINOMA [RCC] - AN EORTC PHASE-II STUDY

      European journal of cancer
    32. DEMULDER PHM; DEWIT R
      EXPERIENCE WITH DOSE AND SCHEDULE VARIATIONS IN GERM-CELL TUMORS

      Anti-cancer drugs
    33. VREUGDENHIL G; DEMULDER PHM; VANHOESEL Q
      SOFT-TISSUE SARCOMA AND HYPERCALCEMIA

      Annals of oncology
    34. SCHORNAGEL JH; VERWEIJ J; DEMULDER PHM; COGNETTI F; VERMORKEN JB; CAPPELAERE P; ARMAND JP; WILDIERS J; DEGRAEFF A; CLAVEL M; SAHMOUD T; KIRKPATRICK A; LEFEBVRE JL
      RANDOMIZED PHASE-III TRIAL OF EDATREXATE VERSUS METHOTREXATE IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER HEAD AND NECK-CANCER COOPERATIVE GROUP-STUDY/

      Journal of clinical oncology
    35. DENOTTER W; HILL FWG; KLEIN WR; KOTEN JW; STEERENBERG PA; DEMULDER PHM; RHODE C; STEWART R; FABER JAJ; RUITENBERG EJ; RUTTEN VPMG
      THERAPY OF BOVINE OCULAR SQUAMOUS-CELL CARCINOMA WITH LOCAL DOSES OF INTERLEUKIN-2 - 67-PERCENT COMPLETE REGRESSIONS AFTER 20 MONTHS OF FOLLOW-UP

      Cancer immunology and immunotherapy
    36. BALEMANS LTM; STEERENBERG PA; KREMER BHA; KOPPENHAGEN FJ; DEMULDER PHM; DENOTTER W
      SPECIFIC TUMOR MEMORY INDUCED BY POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 REQUIRES BOTH HELPER AND CYTOTOXIC T-CELLS

      Cancer immunology and immunotherapy
    37. DRENTH JPH; DEKLEIJN EHMA; DEMULDER PHM; VANDERMEER JWM
      METASTATIC BREAST-CANCER PRESENTING AS FEVER, RASH, AND ARTHRITIS

      Cancer
    38. DEWIT R; STOTER G; SLEIJFER DT; KAYE SB; DEMULDER PHM; HUININK WWT; SPAANDER PJ; DEPAUW M; SYLVESTER R
      4 CYCLES OF BEP VERSUS AN ALTERNATING REGIME OF PVB AND BEP IN PATIENTS WITH POOR-PROGNOSIS METASTATIC TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP

      British Journal of Cancer
    39. DEMULDER PHM; OOSTERHOF GON; BOUFFIOUX C; VANOOSTEROM AT; VERMEYLEN K; SYLVESTER R
      EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA

      British Journal of Cancer
    40. BRUNTSCH U; HEINRICH B; KAYE SB; DEMULDER PHM; VANOOSTEROM A; PARIDAENS R; VERMORKEN JB; WANDERS J; FRANKLIN H; BAYSSAS M; VERWEIJ J
      DOCETAXEL (TAXOTERE) IN ADVANCED RENAL-CELL CANCER - A PHASE-II TRIALOF THE EORTC EARLY CLINICAL-TRIALS GROUP

      European journal of cancer
    41. CLAVEL M; VERMORKEN JB; COGNETTI F; CAPPELAERE P; DEMULDER PHM; SCHORNAGEL JH; TUENI EA; VERWEIJ J; WILDIERS J; CLERICO M; DALESIO O; KIRKPATRICK A; SNOW GB
      RANDOMIZED COMPARISON OF CISPLATIN, METHOTREXATE, BLEOMYCIN AND VINCRISTINE (CABO) VERSUS CISPLATIN AND 5-FLUOROURACIL (CF) VERSUS CISPLATIN (C) IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-III STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP

      Annals of oncology
    42. WAGENER DJT; DEMULDER PHM; WILS JA
      MULTIMODALITY TREATMENT OF LOCALLY ADVANCED PANCREATIC-CANCER

      Annals of oncology
    43. STOTER G; KAYE SB; DEMULDER PHM; LEVI R; RAGHAVAN D
      THE IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS GERM-CELL CARCINOMA

      Journal of clinical oncology
    44. DEMULDER PHM; CAPPELAERE P; COGNETTI F; VERWEIJ J; SCHORNAGEL JH; VERMORKEN JB; KIRKPATRICK A; LEFEBVRE JL
      A PHASE-II STUDY OF PIRARUBICIN IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Cancer chemotherapy and pharmacology
    45. DEMULDER PHM; STERNBERG CN; VANOOSTEROM AT; FOSSA SD
      THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT

      Seminars in oncology
    46. BALEMANS LTM; STEERENBERG PA; KOPPENHAGEN FJ; KREMER BHA; DEMULDER PHM; CLAESSEN AME; SCHEPER RJ; DENOTTER W
      PEG-IL-2 THERAPY OF ADVANCED CANCER IN THE GUINEA-PIG - IMPACT OF THEPRIMARY TUMOR AND BENEFICIAL EFFECT OF CYCLOPHOSPHAMIDE

      International journal of cancer
    47. VERMORKEN JB; VERWEIJ J; DEMULDER PHM; COGNETTI F; CLAVEL M; RODENHUIS S; KIRKPATRICK A; SNOW GB
      EPIRUBICIN IN PATIENTS WITH ADVANCED OR RECURRENT ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP

      Annals of oncology
    48. STERNBERG CN; DEMULDER PHM; VANOOSTEROM AT; FOSSA SD; GIANNARELLI D; SOEDIRMAN JR
      ESCALATED M-VAC CHEMOTHERAPY AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH ADVANCED UROTHELIAL TRACT TUMORS

      Annals of oncology
    49. BALEMANS LTM; MATTIJSSEN V; STEERENBERG PA; VANDRIEL BEM; DEMULDER PHM; DENOTTER W
      LOCOREGIONAL THERAPY WITH POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 OF AN INTRADERMALLY GROWING HEPATOCELLULAR-CARCINOMA IN THE GUINEA-PIGINDUCES T-CELL-MEDIATED ANTITUMOR-ACTIVITY

      Cancer immunology and immunotherapy
    50. DENOTTER W; HILL FWG; KLEIN WR; KOTEN JW; STEERENBERG PA; DEMULDER PHM; RUTTEN VPMG; RUITENBERG EJ
      LOW-DOSES OF INTERLEUKIN-2 CAN CURE LARGE BOVINE OCULAR SQUAMOUS-CELLCARCINOMA

      Anticancer research
    51. GRUTTERS JC; HERMUS ARMM; DEMULDER PHM; BEEX LVAM
      LONG-TERM FOLLOW-UP OF BREAST-CANCER PATIENTS TREATED FOR HYPERCALCEMIA WITH AMINOHYDROXYPROPYLIDENE BISPHOSPHONATE (APD)

      Breast cancer research and treatment
    52. MATTIJSSEN V; PETERS HM; SCHALKWIJK L; MANNI JJ; VANTHOFGROOTENBOER B; DEMULDER PHM; RUITER DJ
      E-CADHERIN EXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA IS ASSOCIATED WITH CLINICAL OUTCOME

      International journal of cancer
    53. PUNT CJA; BURGHOUTS JTM; CROLES JJ; VANLIESSUM PA; DEMULDER PHM; KAMM Y
      CONTINUOUS-INFUSION OF HIGH-DOSE 5-FLUOROURACIL IN COMBINATION WITH LEUCOVORIN AND RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY

      Cancer
    54. TIBBEN JG; BOERMAN OC; CLAESSENS RAMJ; CORSTENS FHM; VANDEUREN M; DEMULDER PHM; VANDERMEER JWM; KEIJSER KGG; MASSUGER LFAG
      CYTOKINE RELEASE IN AN OVARIAN-CARCINOMA PATIENT FOLLOWING INTRAVENOUS ADMINISTRATION OF BISPECIFIC ANTIBODY OC TR F(AB')2/

      Journal of the National Cancer Institute
    55. SCHORNAGEL JH; VERWEIJ J; DEMULDER PHM; COGNETTI F; VERMORKEN JB; CAPPELAERE P; ARMAND JP; WILDIERS J; CLAVEL M; KIRKPATRICK A; LEFEBVRE JL
      A PHASE-II TRIAL OF 10-ETHYL-10-DEAZA-AMINOPTERIN, A NOVEL ANTIFOLATE, IN PATIENTS WITH ADVANCED AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 12:46:41